Exact Mass: 463.3086276

Exact Mass Matches: 463.3086276

Found 32 metabolites which its exact mass value is equals to given mass value 463.3086276, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Gentamicin C2

Gentamicin C2 Pentaacetate Salt

C20H41N5O7 (463.30058360000004)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D005839 - Gentamicins C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic C254 - Anti-Infective Agent > C258 - Antibiotic

   

Sagamicin

2-[4,6-Diamino-3-[3-amino-6-(methylaminomethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol

C20H41N5O7 (463.30058360000004)


S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AA - Antibiotics D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D005839 - Gentamicins C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic C254 - Anti-Infective Agent > C258 - Antibiotic

   

gentamicin C2a

gentamicin C2a

C20H41N5O7 (463.30058360000004)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D005839 - Gentamicins

   

LysoPE(P-18:1(9Z)/0:0)

(2-aminoethoxy)[(2R)-2-hydroxy-3-[(1Z,9Z)-octadeca-1,9-dien-1-yloxy]propoxy]phosphinic acid

C23H46NO6P (463.30625860000004)


LysoPE(P-18:1(9Z)/0:0) is a phospho-ether lipid. Ether lipids are lipids in which one or more of the carbon atoms on glycerol is bonded to an alkyl chain via an ether linkage, as opposed to the usual ester linkage. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodelling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine, and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin and choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0, and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids.

   

Gentamicin C2

2-[(4,6-diamino-3-{[3-amino-6-(1-aminoethyl)oxan-2-yl]oxy}-2-hydroxycyclohexyl)oxy]-5-methyl-4-(methylamino)oxane-3,5-diol

C20H41N5O7 (463.30058360000004)


   

Micronomicin

2-{[4,6-diamino-3-({3-amino-6-[(methylamino)methyl]oxan-2-yl}oxy)-2-hydroxycyclohexyl]oxy}-5-methyl-4-(methylamino)oxane-3,5-diol

C20H41N5O7 (463.30058360000004)


   

Phosphatidylethanolamine lyso alkenyl 18:1

Phosphatidylethanolamine lyso alkenyl 18:1

C23H46NO6P (463.30625860000004)


   
   
   

(1R,2S,3R,4R,6S)-4,6-diamino-3-[3-deoxy-4-C-methyl-3-(methylamino)-beta-L-arabinopyranosyloxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,4,6,7-pentadeoxy-alpha-D-ribo-heptopyranoside

(1R,2S,3R,4R,6S)-4,6-diamino-3-[3-deoxy-4-C-methyl-3-(methylamino)-beta-L-arabinopyranosyloxy]-2-hydroxycyclohexyl 2,6-diamino-2,3,4,6,7-pentadeoxy-alpha-D-ribo-heptopyranoside

C20H41N5O7 (463.30058360000004)


   

HexCer 8:0;2O/9:0

HexCer 8:0;2O/9:0

C23H45NO8 (463.314501)


   

HexCer 9:0;2O/8:0

HexCer 9:0;2O/8:0

C23H45NO8 (463.314501)


   

HexCer 11:0;2O/6:0

HexCer 11:0;2O/6:0

C23H45NO8 (463.314501)


   

HexCer 14:0;2O/3:0

HexCer 14:0;2O/3:0

C23H45NO8 (463.314501)


   

HexCer 13:0;2O/4:0

HexCer 13:0;2O/4:0

C23H45NO8 (463.314501)


   

HexCer 15:0;2O/2:0

HexCer 15:0;2O/2:0

C23H45NO8 (463.314501)


   

HexCer 10:0;2O/7:0

HexCer 10:0;2O/7:0

C23H45NO8 (463.314501)


   

HexCer 12:0;2O/5:0

HexCer 12:0;2O/5:0

C23H45NO8 (463.314501)


   

2-aminoethyl [2-hydroxy-3-[(9Z,12Z)-octadeca-9,12-dienoxy]propyl] hydrogen phosphate

2-aminoethyl [2-hydroxy-3-[(9Z,12Z)-octadeca-9,12-dienoxy]propyl] hydrogen phosphate

C23H46NO6P (463.30625860000004)


   

cis-5-(6-Carboxyhexyl)-trans-4-(cis-1-octenyl)-2,ref.-3-diphenylisoxazolidine

cis-5-(6-Carboxyhexyl)-trans-4-(cis-1-octenyl)-2,ref.-3-diphenylisoxazolidine

C30H41NO3 (463.3086276)


   

(3S)-5beta-(6-Formylhexyl)-4alpha-[(E)-3-hydroxy-1-octenyl]-2,3alpha-diphenylisoxazolidine

(3S)-5beta-(6-Formylhexyl)-4alpha-[(E)-3-hydroxy-1-octenyl]-2,3alpha-diphenylisoxazolidine

C30H41NO3 (463.3086276)


   

Micronomicin

Micronomicin

C20H41N5O7 (463.30058360000004)


S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AA - Antibiotics D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D005839 - Gentamicins C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic C254 - Anti-Infective Agent > C258 - Antibiotic

   

lysophosphatidylethanolamine P-18:1

lysophosphatidylethanolamine P-18:1

C23H46NO6P (463.30625860000004)


A 1-(Z-alk-1-enyl)-sn-glycero-3-phosphoethanolamine in which the Z-alk-1-enyl group contains 18 carbons and has 1 additional double bond

   

NA-Dopamine 22:6(4Z,7Z,10Z,13Z,16Z,19Z)

NA-Dopamine 22:6(4Z,7Z,10Z,13Z,16Z,19Z)

C30H41NO3 (463.3086276)


   

NA-Met 22:4(7Z,10Z,13Z,16Z)

NA-Met 22:4(7Z,10Z,13Z,16Z)

C27H45NO3S (463.311998)


   
   

NMI 8739

NMI 8739

C30H41NO3 (463.3086276)


NMI 8739 is a dopamine D2 autoreceptor agonist, which is an amine conjugate of the DHA carrier and the neurotransmitter dopamine.